Click2learn Forms Alliance With GeneEd To Provide Complete E-Learning Solutions To Pharmaceutical Industry.Business Editors, Technology Writers Combined 21 CFR CFR See: Cost and Freight 11 Infrastructure and Content Solutions Ensure Timely Delivery of Critical, Up-to-Date Scientific Information in Compliance With Federal Standards Click2learn (Nasdaq: CLKS) today announced that it has formed a go-to-market alliance with GeneEd, the leading provider of e-learning content focused on life sciences. Under the agreement, the two companies will jointly develop and market Web-based learning solutions to the healthcare and pharmaceutical industries that marry the comprehensive technology infrastructure of Click2learn's Aspen Learning Platform with GeneEd's unique learning content. "There is a critical need within pharmaceutical companies to rapidly share new information in order to be able to act upon it quickly," said Kevin Oakes, Click2learn chairman and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. . "Our alliance with GeneEd uniquely positions us to serve this highly specialized industry. GeneEd's top-notch content partnered with the power of Aspen technology Aspen Technology (NASDAQ: AZPN) provides software and professional services to the manufacturing and process industries which allows companies to model, manage, and control their operations. AspenTech was founded in 1981 by MIT professor Dr. will help these companies bring their products to market faster, while still meeting exacting quality and regulatory standards." "With its integrated learning management, content management and synchronous learning Synchronous learning refers to a group of people learning the same things at the same time. This is the type of pedagogy practiced in most schools and undergraduate programs, but not in graduate programs. Lecture is an example of synchronous learning. capabilities, Aspen is the ideal vehicle to deliver and manage GeneEd's science-centric e-learning knowledge dissemination platform," said Sunil Maulik, GeneEd chairman and CEO. "Delivering this content to pharmaceutical company employees anytime, anywhere, will help increase their productivity and, in turn, will help these organizations realize significantly increased business performance." Aspen complies with strict federal rules regarding electronic records through its 21 CFR 11 compliance module, making it an ideal tool for pharmaceutical companies by enhancing their ability to digitally enter, track and manage updates to training records for more cost-effective administration of its learning programs. About Click2learn Click2learn (Nasdaq: CLKS) is a provider of enterprise software for Global 2000 organizations seeking to capture, manage and disseminate knowledge throughout their extended enterprise. Using Click2learn's Aspen Enterprise Learning Platform, organizations can deploy highly interactive, personalized learning initiatives to achieve strategic business objectives. Many of the world's best-known corporations use Click2learn's technology to improve workforce performance, educate customers, and publish large volumes of learning content. Click2learn's clients include Accenture, Albertson's, American Airlines American Airlines Major U.S. airline. American was created through a merger of several smaller U.S. airlines and incorporated in 1934. It continued to buy the routes of other airlines, becoming an international carrier in the 1970s; its routes include South America, the , AstraZeneca, Century 21, Fujitsu, Microsoft, Pfizer, Symantec, and Towers Perrin Towers Perrin is a global professional services firm. It was established 1 March 1934 as Towers, Perrin, Forster & Crosby. The umbrella name of Towers Perrin was adopted in 1987. . Based in Bellevue, Wash., Click2learn (www.click2learn.com, 800/448-6543) operates offices in the United States United States, officially United States of America, republic (2005 est. pop. 295,734,000), 3,539,227 sq mi (9,166,598 sq km), North America. The United States is the world's third largest country in population and the fourth largest country in area. and Europe. About GeneEd GeneEd, Inc. was founded in 1997 to provide life science and healthcare e-learning solutions through the creation of compelling, multimedia-based training, using the Internet and corporate Intranets as the primary delivery platform. GeneEd uses the best life science content, combined with a validated methodology for repurposing, to rapidly create basic and advanced curricula in the areas of genomics, drug discovery and development, pharmacogenetics Pharmacogenetics Definition Pharmacogenetics is the study of how the actions of and reactions to drugs vary with the patient's genes. Description and clinical genomics, and therapeutic and diagnostic products. GeneEd, Inc. is a privately held company privately held company A firm whose shares are held within a relatively small circle of owners and are not traded publicly. headquartered in San Francisco, California “San Francisco” redirects here. For other uses, see San Francisco (disambiguation). The City and County of San Francisco (EN IPA: [sænfrənˈsɪskoʊ] . Visit http://www.GeneEd.com for additional information about GeneEd and its courseware. This announcement contains forward-looking statements that involve risks and uncertainties, including information contained in this document where statements are preceded by, followed by or include the words "believes," "plans," "intends," "expects," "anticipates" or similar expressions. For such statements, The Company claims the protection of the safe harbor Safe Harbor 1. A legal provision to reduce or eliminate liability as long as good faith is demonstrated. 2. A form of shark repellent implemented by a target company acquiring a business that is so poorly regulated that the target itself is less attractive. for forward-looking statements contained in the Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and of 1995. Actual results may differ materially from the results predicted, and reported results should not be considered as an indication of future performance. Factors that could cause actual results to differ from those contained in the forward-looking statements include, market acceptance of Click2learn's e-learning solutions and competing e-learning offerings, the ability to successfully implement Click2learn's solutions and increase revenues, the ability to successfully address technological developments and standards and the risk factors set forth in filings the Company has made with the SEC. Click2learn, Aspen and ToolBook are trademarks of Click2learn. All other company and product names are the trademarks of their respective owners. |
|
Printer friendly
Cite/link
Email
Feedback
Reader Opinion